Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cisplatin Adverse Reaction”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNot Yet RecruitingNCT06929468
What this trial is testing

Cisplatin-induced Cochlear and Vestibular Damage in Head and Neck Cancer

Who this might be right for
Ototoxic Hearing LossOtotoxicity, Drug-InducedCisplatin-induced Hearing Loss+8 more
Simon Jäger 55
Testing effectiveness (Phase 2)Study completedNCT00006105
What this trial is testing

Gemcitabine, Cisplatin, and Amifostine Following Surgery in Treating Patients With Locally Advanced Bladder Cancer

Who this might be right for
Bladder CancerDrug/Agent Toxicity by Tissue/Organ
University of Chicago 37
Not applicableStudy completedNCT05789316
What this trial is testing

Head and Neck Cancer Survivorship Ototoxicity Screening (SOS)

Who this might be right for
Head and Neck Cancer SurvivorsCancer of the Head and Neck Surviors
Washington University School of Medicine 55
Not applicableStudy completedNCT03400709
What this trial is testing

Protective Role of N-acetylcisteine From Cisplatin-induced Ototoxicity in Patients With Head and Neck Cancer

Who this might be right for
Cisplatin Adverse ReactionHearing Loss Ototoxic
Hospital San Juan de Dios, Santiago 45
Testing effectiveness (Phase 2)Looking for participantsNCT07169851
What this trial is testing

Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer

Who this might be right for
NauseaVomitingDrug-Related Side Effects and Adverse Reactions+1 more
Eli Lilly and Company 204
Large-scale testing (Phase 3)Study completedNCT00324298
What this trial is testing

Bleomycin, Etoposide, and Cisplatin in Treating Patients With Metastatic Germ Cell Cancer of the Testicles

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganTesticular Germ Cell Tumor
Queen Mary University of London 210
Not applicableStudy completedNCT00458887
What this trial is testing

Assessing Ear Damage in Young Cancer Patients Treated With Cisplatin

Who this might be right for
OtotoxicityUnspecified Childhood Solid Tumor, Protocol Specific
Children's Oncology Group 301
Testing effectiveness (Phase 2)UnknownNCT01108601
What this trial is testing

Transtympanic Ringer's Lactate for the Prevention of Cisplatin Ototoxicity

Who this might be right for
Hearing Loss
McGill University Health Centre/Research Institute of the McGill University Health Centre 20
Post-approval studies (Phase 4)Study completedNCT01372904
What this trial is testing

Prevention of Cisplatin-Induced Hearing Loss by Intratympanic Dexamethasone Treatment

Who this might be right for
Cisplatin Ototoxicity
Meir Medical Center 30
Testing effectiveness (Phase 2)Looking for participantsNCT03480971
What this trial is testing

Treatment of Radiation and Cisplatin Induced Toxicities with Tempol

Who this might be right for
MucositisNephrotoxicityOtotoxicity
Matrix Biomed, Inc. 120
Large-scale testing (Phase 3)Study completedNCT01829178
What this trial is testing

Evaluation of Effects of Silymarin on Cisplatin Induced Nephrotoxicity in Upper Gastrointestinal Adenocarcinoma

Who this might be right for
Upper GI CancerCisplatin Adverse Reaction
Tehran University of Medical Sciences 30
Early research (Phase 1)Not Yet RecruitingNCT07824843
What this trial is testing

Safety Study of GMDTC Injection in Participants With Solid Tumors and Cisplatin-Induced Renal Dysfunction

Who this might be right for
Cisplatin NephrotoxicityCisplatin Adverse Reaction
Guangdong Jianersheng Pharmaceutical Technology Co., Ltd. 60
Testing effectiveness (Phase 2)UnknownNCT00003251
What this trial is testing

Amifostine Plus Chemotherapy and Radiation Therapy in Treating Patients With Advanced, Unresectable Head and Neck Cancer

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganHead and Neck CancerRadiation Toxicity
University of Illinois at Chicago 46
Not applicableUnknownNCT06019520
What this trial is testing

Role of N-Acetylcysteine for Prevention of Cisplatin-induced Nephrotoxicity

Who this might be right for
Drug Toxicity
Foundation University Islamabad 70
Not applicableStudy completedNCT02099786
What this trial is testing

Randomized Trial Comparison of Ototoxicity Monitoring Programs

Who this might be right for
Cisplatin OtotoxicityHearing Loss
VA Office of Research and Development 47
Testing effectiveness (Phase 2)Ended earlyNCT02281006
What this trial is testing

Efficacy of Trans-tympanic Injections of a Sodium Thiosulfate Gel to Prevent Cisplatin-induced Ototoxicity

Who this might be right for
DDPHead and Neck CancerAdverse Effect
CHU de Quebec-Universite Laval 13
Testing effectiveness (Phase 2)Study completedNCT00003580
What this trial is testing

Amifostine to Treat Side Effects of Treatment in Patients Receiving Radiation Therapy and Cisplatin for Advanced Head and Neck Cancer

Who this might be right for
Drug/Agent Toxicity by Tissue/OrganHead and Neck CancerOral Complications+1 more
University of Tennessee
Testing effectiveness (Phase 2)WithdrawnNCT01451853
What this trial is testing

SPI-1005 for Prevention and Treatment of Chemotherapy Induced Hearing Loss

Who this might be right for
Lung CancerHead and Neck CancerHearing Loss+3 more
Sound Pharmaceuticals, Incorporated
Testing effectiveness (Phase 2)Looking for participantsNCT07364747
What this trial is testing

Protective Effect of Acetylcysteine Against Cisplatinum-Induced Ototoxicity: A Randomized Controlled Trial

Who this might be right for
Cisplatin-induced OtotoxicitySensorineural Hearing LossOtotoxicity+1 more
Siriraj Hospital 40
Testing effectiveness (Phase 2)Study completedNCT00003811
What this trial is testing

Combination Chemotherapy Plus Amifostine in Treating Children With Malignant Germ Cell Tumors

Who this might be right for
Childhood Germ Cell TumorDrug/Agent Toxicity by Tissue/OrganExtragonadal Germ Cell Tumor+1 more
Children's Oncology Group 27
Next Page